Therapeutic use of imidazole-5-carboxylic acid derivatives
AssigneeShanghai Allist Pharmaceuticals, Inc.
InventorJianhui Guo
Life of this patent
Estimating the term…
Abstract
The invention discloses the use of 2-butyl-4-chloro-1-[2′-(1H-tetrazol-5-yl)1,1′-biphenyl-methyl]-imidazole-5-carboxylic acid, 1-[(isopropoxycarbonyl)oxy] methyl ester and the pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of the damage of a target organ caused by hypertension. It particularly discloses the use of this compound in the manufacture of a medicament for the treatment of left ventricular hypertrophy, renal dysfunction, aorta thickening caused by hypertension, which provides an effective drug and method for the treatment of the damage of target organs for hypertension patients.
Claims15
-10. (canceled)
A method for the treatment of the damage of a target organ caused by hypertension, comprising administering to a subject in need thereof a compound of formula (I) or a pharmaceutically acceptable salt thereof
A method for the treatment of the damage of a target organ caused by hypertension, comprising administering to a subject in need thereof a composition comprising the compound of formula (I) or a pharmaceutically acceptable salt thereof
A pharmaceutical composition for oral or sublingual administration, which contains about 50 mg-about 1000 mg of a compound of formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier
Dependencies are inferred from the claim text.